This statistic illustrates the consumption of oral antidiabetic drugs in France in 2011, by molecule. That year, the consumption of sulphonamides in France amounted to about 18 daily doses per 1,000 inhabitants per day.
Consumption of oral antidiabetic drugs in France in 2011, per molecule (in doses per 1,000 inhabitants)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Top diabetes medications in Canada in 2018, by share of spending
- Premium Statistic Market distribution of diabetic drug products in China 2021
- Premium Statistic Sales distribution of diabetic drugs in China 2020, by category
- Premium Statistic Market size of diabetes medication sector in China 2016-2022
- Premium Statistic Net sales of diabetes medicines of Novo Nordisk in Greater China 2022, by type
- Premium Statistic Net sales of insulin medications of Novo Nordisk in Greater China 2022, by type
- Premium Statistic Net sales of diabetes medicines of Novo Nordisk in Greater China 2022, by product
- Premium Statistic Medication: daily use in France 2012-2019
- Premium Statistic Market size of human insulin in China 2018-2030
- Premium Statistic Breakdown of oral hypoglycemic drug sales in hospitals in China 2018-2030, by agent
About the region
10
- Premium Statistic Rate of people treated for diabetes in France 2018, by region
- Premium Statistic Number of people treated for diabetes in France 2018, by region
- Premium Statistic Rate of people treated for diabetes in France 2017, by age
- Premium Statistic Diabetes: health insurance expenses in France 2017, by type
- Premium Statistic Volume of medicines dispensed in pharmacies reimbursed in France 2014, by class
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Net profit of Boiron laboratories 2013-2022, per share
- Premium Statistic Net investments of Boiron laboratories 2014-2022
- Premium Statistic Boiron laboratories turnover in France 2022, by region
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
Selected statistics
3
Other regions
10
- Basic Statistic England: net ingredient cost for drugs used in diabetes 2005-2023
- Premium Statistic Worldwide cases of type 2 diabetes 2015-2025, by country
- Premium Statistic Estimated number of adults with prediabetes in China 2011-2045
- Premium Statistic Treated chronic health conditions among Canadian First Nations youth 2015-2016
- Premium Statistic Prevalence of gestational diabetes among new U.S. mothers in 2016, by state
- Premium Statistic Wales: share of patients receiving care processes for diabetes 2021-22, by type
- Premium Statistic Number of children with type 1 diabetes in Denmark 2018, by age group
- Premium Statistic Share of adults with diabetes in Scotland 2003-2022, by gender
- Basic Statistic Sufferers from chronic health conditions in South Africa 2019, by disease
- Premium Statistic Share of population with diabetes APAC 2021, by country
Related statistics
10
- Basic Statistic Health center patients in U.S. by chronic condition and health status 2019
- Premium Statistic Workforce of Boiron laboratories in the World in 2022, by region
- Premium Statistic Personnel costs of Boiron laboratories 2012-2022
- Premium Statistic Value of assets of Boiron laboratories in 2022, by type
- Premium Statistic Boiron's capital breakdown at the end of 2022, by shareholder
- Premium Statistic Distribution of the workforce of Boiron laboratories in 2022, by activity sector
- Premium Statistic Value of the liabilities of Boiron laboratories, by type in 2022
- Premium Statistic Dividend of Boiron laboratories 2013-2022, per share
- Premium Statistic Worldwide workforce of Boiron laboratories 2022, by gender
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
Further related statistics
9
- Expenditure worldwide on diabetes by market 2013-2018
- Number of patients with non-communicable diseases in India 2010
- U.S. insulin market distribution: leading companies 2011
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Leading causes of death among the white population in the United States in 2020
- Leading causes of death among Black U.S. residents in 2020
- Consumer rating of impact of type of calories on weight gain 2013-2021
- Leading European medtech countries based on market capitalization 2014
- Chinese insulin market distribution: leading companies 2011
Further Content: You might find this interesting as well
Statistics
- Expenditure worldwide on diabetes by market 2013-2018
- Number of patients with non-communicable diseases in India 2010
- U.S. insulin market distribution: leading companies 2011
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Leading causes of death among the white population in the United States in 2020
- Leading causes of death among Black U.S. residents in 2020
- Consumer rating of impact of type of calories on weight gain 2013-2021
- Leading European medtech countries based on market capitalization 2014
- Chinese insulin market distribution: leading companies 2011
Irdes. (June 11, 2013). Consumption of oral antidiabetic drugs in France in 2011, per molecule (in doses per 1,000 inhabitants) [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/768295/consumption-antidiabetic-oral-molecule-la-france/
Irdes. "Consumption of oral antidiabetic drugs in France in 2011, per molecule (in doses per 1,000 inhabitants)." Chart. June 11, 2013. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/768295/consumption-antidiabetic-oral-molecule-la-france/
Irdes. (2013). Consumption of oral antidiabetic drugs in France in 2011, per molecule (in doses per 1,000 inhabitants). Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/768295/consumption-antidiabetic-oral-molecule-la-france/
Irdes. "Consumption of Oral Antidiabetic Drugs in France in 2011, per Molecule (in Doses per 1,000 Inhabitants)." Statista, Statista Inc., 11 Jun 2013, https://www.statista.com/statistics/768295/consumption-antidiabetic-oral-molecule-la-france/
Irdes, Consumption of oral antidiabetic drugs in France in 2011, per molecule (in doses per 1,000 inhabitants) Statista, https://www.statista.com/statistics/768295/consumption-antidiabetic-oral-molecule-la-france/ (last visited April 19, 2024)
Consumption of oral antidiabetic drugs in France in 2011, per molecule (in doses per 1,000 inhabitants) [Graph], Irdes, June 11, 2013. [Online]. Available: https://www.statista.com/statistics/768295/consumption-antidiabetic-oral-molecule-la-france/